COMPASS THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
COMPASS THERAPEUTICS, INC. (CMPX) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$13.96 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-05
- COMPASS THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$13.96M.
- COMPASS THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$10.37M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$13.96M 10-K · filed 2026-03-05 |
| 2024-12-31 | -$10.37M 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |